home genetic news bioinformatics biotechnology literature journals ethics positions events sitemap


UBBFriend: Email This Page to Someone!
  HUM-MOLGEN
  Biotechnical requests and sources
  AnaSpec Introduces Ten New Catalog Peptides

Post New Topic  Post A Reply
profile | register | preferences | faq | search

next newest topic | next oldest topic
Author Topic:   AnaSpec Introduces Ten New Catalog Peptides
anaspec
Member
posted 01-02-2008 08:42 PM     Click Here to See the Profile for anaspec   Click Here to Email anaspec     Edit/Delete Message Reply w/Quote
January 2, 2008 – San Jose, CA

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid.


MSL8; [Met256]-OVA (257-264)- Cat# 62573-5
Sequence: MSIINFEKL

MSL8; [Met256]-OVA (257-264)- Cat# 62573-1
Sequence: MSIINFEKL

OVA (257-264); amide- Cat# 62572-5
This octameric peptide is amino acids 257 to 264 amidated fragment of ovalbumin (OVA); a class I (Kb)-restricted peptide epitope of OVA; presented by the class I MHC molecule; H-2Kb.
Sequence: SIINFEKL-NH2

OVA (257-264); amide- Cat# 62572-1
This octameric peptide is amino acids 257 to 264 amidated fragment of ovalbumin (OVA); a class I (Kb)-restricted peptide epitope of OVA; presented by the class I MHC molecule; H-2Kb.
Sequence: SIINFEKL-NH2

OVA (323-339); amide- Cat# 62571-5
This peptide is amino acids 323 to 339 amidated fragment of ovalbumin (OVA); the H-2b-restricted OVA class II epitope. This peptide is recognized by many T cells because it contains multiple T cell epitopes. This OVA fragment contains a nested set of CD4+ T cell epitopes. OVA 323 to 339 can be presented by I-Ad in at least three binding registers. The residues 327 to 333 are critical for peptide binding to I-Ad
Sequence: ISQAVHAAHAEINEAGR-NH2

OVA (323-339); amide- Cat# 62571-1
This peptide is amino acids 323 to 339 amidated fragment of ovalbumin (OVA); the H-2b-restricted OVA class II epitope. This peptide is recognized by many T cells because it contains multiple T cell epitopes. This OVA fragment contains a nested set of CD4+ T cell epitopes. OVA 323 to 339 can be presented by I-Ad in at least three binding registers. The residues 327 to 333 are critical for peptide binding to I-Ad
Sequence: ISQAVHAAHAEINEAGR-NH2

HEL (46-61)- Cat# 60504-1
This peptide is amino acids 46 to 61 fragment of the hen egg lysozyme (HEL). Lysozyme is anti-bacterial enzyme found in high concentration in the egg white. HEL was used in in MHC related studies; and tested as a part of anti-microbial vaccines.
Sequence: NTDGSTDYGILQINSR

Vesicular Stomatitis Virus Nucleoprotein (52-59); VSV-8- Cat# 60785
This octapeptide is amino acids 52 to 59 fragment of the the vesicular stomatitis virus (VSV) nucleoprotein. VSV-8 is derived from the VSV nucleoprotein that is expressed in the cytosol of the infected cells. CTL response against VSV in H-2Kb mice is directed against this single VSV-8 immunodominant peptide. This 8 peptide forms complex with murine MHC class I molecule H-2Kb; which is similar to human HLA class I. This peptide was used in numerous MHC-binding studies and T-cell assays.
Sequence: RGYVYQGL

LEAP-1; Hepcidin; human- Cat# 61432
This 25 amino acid residues Liver-Expressed Antimicobial Peptide 1 (LEAP-1) is also known as hepcidin. LEAP-1 is a liver-specific peptide; but may be detected in the heart and brain at a lesser amount.
Sequence: DTHFPICIFCCGCCHRSKCGMCCKT (Disulfide bridges: 7-23; 10-22; 11-19; 13-14)

RNase S Complex Peptide- Cat# 62416
This peptide is a dead-end modified peptide from Ribonuclease S complex.
Sequence: Ac-KETAAAKFERQHMDSSTSA-NH2

Fmoc-Lys(4,5-dimethoxy-2-nitro-benzyloxycarbonyl)-OH- Cat# 62574-500/ Cat# 62574-1000
Light-sensitive Compatible with standard Fmoc protocols Nvoc group removed by photo-cleavage

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry. Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

For more information visit www.anaspec.com

IP: 68.120.108.218

All times are ET (US)

next newest topic | next oldest topic

Administrative Options: Close Topic | Archive/Move | Delete Topic
Post New Topic  Post A Reply
Hop to:

Contact Us | HUM-MOLGEN

Copyright by HUM-MOLGEN 1995-2015

Powered by: Ultimate Bulletin Board, Version 5.44a
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.